Refine by
Drug Platform Candidate Articles & Analysis: This-Year
3 news found
Through this program, investigators or technology transfer offices with potential oncology drug candidates, in the early discovery or development phases, can submit their application to POAI for consideration. The POAI platform provides data (wet lab and active ML modeling) back to researchers based on access to an otherwise unreachable number ...
Hit identification and optimization Creative Diagnostics provides comprehensive support for drug screening using virtual, biochemical, biophysical, cellular and phenotyping platforms. ...
Ace Therapeutics launches its cutting-edge in vivo models of diabetes mellitus. These models—chemically induced, genetically engineered, or diet-induced—have the potential to advance diabetes research by giving scientists the means to support the identification and development of novel treatment approaches. Diabetes mellitus, a chronic condition characterized by elevated blood ...